Marfan syndrome
Marfan syndrome's disease overview
Marfan syndrome in people with long limbs is a genetic disorder that affects connective tissue (supportive fibers, organ connection and other structures in the body). Because connective tissue is found throughout the body, Marfan syndrome affects the development and function of many organs. However, this syndrome usually affects the heart, eyes, blood vessels and bones.
Medicine of Marfan syndrome
The most obvious sign of this disorder includes tall, thin, abnormal long limbs , fingers, long toes, unmeasurable, protruding sternum or concave, curved spine, loose joints, large and flat feet, heavy myopia. The effects caused by marfan syndrome may be mild or severe. If the aorta (large blood vessels carry blood from the heart to the rest of the body) is affected, this condition can be life -threatening.
Marfan syndrome was named after French doctor Antoine Marfan, the first person to describe this disorder in 1896, determined by Francesco Ramirez related to the 1991 gene. Marfan syndrome, a genetic mutation that causes defects in the production of fibrillin (is a protein found in connective tissue).
Marfan syndrome has a frequency of 1/5000, inherited (the child of a Marfan patient with a probability of being ill is 50%). About 25–30% of cases are due to mutations, no family history. The signs of marfan syndrome change, different even for people in the same family. Some people are only mild, some people have dangerous complications.
The consequences of Marfan syndrome :
Causes of Marfan syndrome's disease
What mutations marfan syndrome?
Marfan syndrome occurs due to a defect in the Fibrillin-1 gene (FBN1).
FBN1 is the gene that produces protein needed to make elastic fibers in connective tissue. This gene mutation can reduce the number and quality of Fibrillin-1 in connective tissue, leading to the weakening of structures.
About 75% of people with Marfan syndrome inheriting abnormal genes from their parents are sick people.
About 25% of Marfan syndrome cases are the result of a new mutation in the gene.
A person with a Marfan syndrome has 50% of the chance of transmitting disease to the child
Parents are not infected with a probability of 1/10000 to give birth to a child with Marfan syndrome
Symptoms of Marfan syndrome's disease
Symptoms of this condition may appear during embryo and young children or later in life when children grow up. Some symptoms may worsen with age include:
Bone system: This disorder manifests itself in each person. The visible symptoms often appear in bones and joints including:
Loose joints
The bent spine
Cardiovascular system:
Eyes:
Heavy myopia
The nervous system: Due to the abnormal structure of the epidural that can cause discomfort such as abdominal pain, pain or numbness in the leg.
Skin: Many people with Marfan syndrome have stretch marks on the skin without any weight change. Stretch marks can occur at any age and do not harm health. However, people with Marfan syndrome are at high risk of hernia or groin
Lung:
A few people with Marfan syndrome may have respiratory disorders related to sleep such as snoring, or sleep apnea.
People at risk for Marfan syndrome's disease
Marfan syndrome is a fairly common condition, affecting 1/5000 people. This situation can appear in everyone and all ages and regardless of gender.
The biggest risk factor is genetics from parents suffering from this situation.
Prevention of Marfan syndrome's disease
There is no preventive method for cases of marfan syndrome due to genetic mutations.
For people with Marfan syndrome, to prevent genetic disease for children (at a rate of 50%), patients should be inherited before giving birth.
There is currently no diagnostic test that can determine whether a child who has not been born has a Marfan syndrome, but the genetic advice helps families with disease genes to understand. Genetic risk for children.
Measures to prevent severe progression in people with Marfan syndrome:
Marfan syndrome with symptoms of aortic aneurysms should be checked regularly by X-ray and ultrasound.
Diagnostic measures for Marfan syndrome's disease
The diagnosis of Marfan syndrome is relatively difficult because many other connective tissue disorders have similar signs and symptoms.
There is no specialized test used to diagnose Marfan syndrome. The diagnosis will be based on medical history and signs related to this syndrome and subclinical.
Tests often used to diagnose the disease include:
Echocardiography: To check the condition of the heart valve and the size of the aorta.
Check with the slot light: to check whether the lenses are deviated or not, whether the cataract or the retina is separated. The doctor will put the drug into the eye of the patient to stretch the eye during the test
Check eye pressure: to check the pressure inside the eyeball. Doctors often use eye drops before proceeding.
Marfan syndrome's disease treatments
Currently, there is no way to treat Marfan syndrome.
Treatment methods often focus on reducing the impact of different symptoms in different parts:
Cardiovascular:
Bones and joints:
Vision:
Lung:
People with Marfan syndrome if detected early, closely monitored and treated appropriately, the post -preparation improvement is significantly improved, and may even live almost normal people. Previously, the average life expectancy of the patient with Marfan syndrome was 45 years old, death mainly due to cardiovascular complications. Currently, thanks to early detection and appropriate treatment, longevity has increased, there are cases of living over 70 years old.
See also:

Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions